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Abstract
Despite the many approaches to study differential splicing from RNA-seq, many challenges remain unsolved, including
computing capacity and sequencing depth requirements. Here we present SUPPA2, a new method that addresses
these challenges, and enables streamlined analysis across multiple conditions taking into account biological variability.
Using experimental and simulated data, we show that SUPPA2 achieves higher accuracy compared to other methods,
especially at low sequencing depth and short read length. We use SUPPA2 to identify novel Transformer2-regulated
exons, novel microexons induced during differentiation of bipolar neurons, and novel intron retention events during
erythroblast differentiation.
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Background
Alternative splicing is related to a change in the relative
abundance of transcript isoforms produced from the same
gene [1]. Multiple approaches have been proposed to study
differential splicing from RNA sequencing (RNA-seq) data
[2, 3]. These methods generally involve the analysis of
either transcript isoforms [4–7], clusters of splice junctions
[8, 9], alternative splicing events [10, 11], or exonic regions
[12]. Relative abundances of the splicing events or
transcript isoforms are generally described in terms of a
percentage or proportion spliced-in (PSI) and differential
splicing is given in terms of the difference of these relative
abundances, or ΔPSI, between conditions [13, 14]. PSI
values estimated from RNA-seq data have shown a good
agreement with independent experimental measurements,
and the magnitude of ΔPSI represents a good indicator of
biological relevance [10, 15]. However, despite the multiple
improvements achieved by recent RNA-seq analysis
methods, many challenges remain unresolved. These
include the limitations in processing time for current
methods, the computational and storage capacity required,
as well as the constraints in the number of sequencing
reads needed to achieve high enough accuracy.
An additional challenge for RNA-seq analysis is the lack
of robust methods to account for biological variability
between replicates or to perform meaningful analyses of
differential splicing across multiple conditions. Although
many methods assess the estimation uncertainty of the
splicing event or transcript isoforms [10–12], they gener-
ally do so on individual events rather than considering the
genome-wide distribution. Additionally, most methods
determine the significance of differential splicing by per-
forming tests directly on read counts, leaving the selection
of relevant ΔPSI values to an arbitrary cut-off. In other
cases, fold changes instead of ΔPSI are given, which are
even harder to interpret in terms of splicing changes.
We showed before that transcriptome quantification
could be leveraged for the fast estimation of event PSI
values with high accuracy compared with experimental
and simulated datasets [16]. We now present here a new
method for analyzing differential splicing, SUPPA2,
which builds upon these principles to address the
current challenges in the study of differential splicing,
and taking into account biological variability. Compared
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with other existing approaches for differential splicing
analysis using RNA-seq data, SUPPA2 provides several
advantages. SUPPA2 can work with multiple replicates
per condition and with multiple conditions. Additionally,
SUPPA2 estimates the uncertainty of ΔPSI values as a
function of the expression of transcripts involved in the
event, taking into account all events genome-wide to test
the significance of an observed ΔPSI, thereby directly
estimating the biological relevance of the splicing change
without relying on arbitrary ΔPSI cut-offs. Moreover,
SUPPA2 incorporates the possibility to perform cluster-
ing of differentially spliced events across multiple condi-
tions to identify groups of events with similar splicing
patterns and common regulatory mechanisms. In con-
clusion, SUPPA2 enables cost-effective use of RNA-seq
for the robust and streamlined analysis of differential
splicing across multiple biological conditions. The soft-
ware described here is available at https://github.com/
comprna/SUPPA.
Results
SUPPA2 monitors uncertainty to determine differential
splicing
We showed before that the inclusion levels of alternative
splicing events can be readily calculated from transcript
abundances estimated from RNA-seq data with good
agreement with experimental measurements and with
other methods based on local measurements of splicing
[16]. SUPPA2 extends this principle to measure differen-
tial splicing between conditions by exploiting the vari-
ability between biological replicates to determine the
uncertainty in the PSI values (see “Methods”). To illus-
trate our approach and to evaluate the dynamic range of
SUPPA2 we used it to analyze RNA-seq data obtained
after the double knockdown of TRA2A and TRA2B spli-
cing regulators compared with controls [17] (Fig. 1a).
The differences in PSI value for each event between bio-
logical replicates are higher at low expression, in agree-
ment with the expected higher variability at low read
count. This biological variability provides information on
the uncertainty of the PSI estimates. The significance of
an observed ΔPSI value between conditions will depend
on where in the distribution of the uncertainty it falls. A
large splicing change (|ΔPSI| value) may not be signifi-
cant if it falls within a range of high uncertainty, whereas
a small splicing change may be defined as robustly sig-
nificant if it falls in the low uncertainty range. SUPPA2
estimates the significance considering the distribution
between replicates for all events with similar transcript
abundance; hence, it provides a lower bound for signifi-
cant |ΔPSI| values that vary with the expression of the
transcripts describing the event (Fig. 1b; see “Methods”).
The description of the uncertainty in terms of transcript
abundances, given in transcripts per million (TPM) units,
rather than read counts provides several advantages.
These include speed, as there is no need to store or go
back to read information, as well as interpretability and
a 
b 
c 
Fig. 1 Overview of SUPPA2 differential splicing and time
benchmarking analysis. a The central panel displays the ΔPSI values
between replicates (y-axis) as a function of the average transcript
abundance (x-axis), using data from [17] (“Methods”). The attached
panels display the ΔPSI values along the x-axis (top panel) and along
the y-axis (right panel). The green dot represents an example of ΔPSI
observed between conditions. The top-right panel shows the
between-replicate |ΔPSI| density distribution against which an ob-
served |ΔPSI| is compared to obtain a p value. This density distribu-
tion is calculated from events with similar associated expression. b
The central panel displays the ΔPSI values (y-axis) between condi-
tions (green) or between replicates (gray) as a function of the aver-
age transcript abundance (x-axis) in log10(TPM + 0.01) scale. Only
events with p value < 0.05 according to SUPPA2 are plotted in green.
The attached panels display the distribution of the significant ΔPSI
values along the x-axis (top panel) and along the y-axis (right panel).
c Time performance of SUPPA2 compared to rMATS, MAJIQ, and
DEXSeq in the differential splicing analysis between two conditions,
with three replicates each [17]. Time (y-axis) is given in minutes and
in each case it does not include the read mapping, transcript
quantification steps, or the calculation of PSI values
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application range, as transcript abundances are already
normalized for transcript length and remain stable at dif-
ferent library sizes. More details on these advantages are
provided below.
We compared SUPPA2 results with three other
methods that calculate differential splicing using multiple
replicates per condition: rMATS [11] and MAJIQ [9],
which describe changes in terms of ΔPSI, and DEXSeq
[12], which uses fold changes. Importantly, we found that
SUPPA2 was much faster than the other methods, devot-
ing 24 s to the PSI quantification and about 32 min and
47 s for differential splicing analysis on the same datasets
(Fig. 1c). Since SUPPA2 performs the significance test
directly on the ΔPSI values without needing to go back to
the read data, it hence provides unmatched speed for
differential splicing analysis. Comparing the results ob-
tained with each method (Additional file 1: Figure S1), we
observed that rMATS and DEXSeq detect many appar-
ently significant events with small inclusion changes that
are not distinguishable from the variability between bio-
logical replicates, whereas SUPPA2 and MAJIQ separate
well these two distributions. As SUPPA2 exploits the
between-replicate variability to test for significance, it
avoids the use of an arbitrary global |ΔPSI| threshold to
identify biologically relevant events and detects significant
events across a wide range of gene expression values
(Additional file 1: Figure S1). This feature of SUPPA2
should hence better rationalize |ΔPSI| threshold cut-offs.
SUPPA2 provides high accuracy at low sequencing depth
and with short read lengths
To test the accuracy of SUPPA2 with different sequencing
settings and compare it with other methods, we simulated
277 exon-cassette (SE) events and 318 alternative splice
site (A5/A3) events with |ΔPSI| > 0.2 between two condi-
tions with three replicates per condition (Additional file 1:
Figure S2a). To perform a balanced comparison, we con-
sidered the same number of negative controls, consisting
of different SE and A5/A3 events with arbitrary PSI values
but with no simulated change between conditions
(Additional file 2: Table S1; “Methods”). We simulated
genome-wide RNA-seq reads using RSEM [18] at different
sequencing depths (120, 60, 25, 10, and 5 million (M) 100-
nucleotide (nt) paired-end reads per sample) and for
different read lengths (100, 75, 50, and 25 nt at a fixed
depth of 25 M paired-end reads). Despite the differences
in the numbers and length of the reads (Additional file 2:
Table S2), the genes containing the positive and negative
events used for benchmarking showed similar distribu-
tions of expression values at all depths and read lengths
(Additional file 1: Figure S2b). We then calculated differ-
entially spliced events with SUPPA2, rMATS, MAJIQ, and
DEXSeq and evaluated the detection rate and accuracy on
the simulated events (Additional file 2: Table S3).
The detection rate was calculated as the proportion of
simulated positive and negative cassette events that each
method was able to measure from the RNA-seq data,
i.e., the event was recovered regardless of whether it was
detected as significant. The detection rate of SUPPA2
was superior than the other methods in all conditions,
even at low depth and for shorter reads (Additional file 1:
Figure S2c). We also measured the true positives, i.e.,
the positive events that were observed to change signifi-
cantly and in the same direction by each method, and
the false positives, i.e., the negative events predicted to
change significantly. For SE events the true positive rates
were comparable across different sequencing depths
(Fig. 2a). On the other hand, for shorter read length
SUPPA2 recovered a higher proportion of true positives
compared to the other methods (Fig. 2b). For A5/A3
events we also observed a similar decay in true positives
with sequencing depth for all methods (Fig. 2c) and a
higher accuracy of SUPPA2 with shorter read lengths
(Fig. 2d). The same accuracies were observed if we
imposed in addition the cutoff |ΔPSI| > 0.2 for the pre-
dictions (Additional file 2: Table S3). The reduced pro-
portion of true positives at low depth and shorter read
length in other methods was probably due to them rely-
ing on having sufficient junction and/or exonic reads.
Additionally, even though SUPPA2 recovered in general
more negative events, i.e., events simulated to be not
differentially spliced, the false positive rate remained
comparable to the other methods, and below 5% for all
conditions (Additional file 2: Table S3). To further evalu-
ate the accuracies of the different methods, we computed
receiver operating characteristic (ROC) and precision-
recall (PR) curves (Additional file 2: Table S3). MAJIQ
and SUPPA2 show similar areas under the ROC and PR
curves, which drop at low depth and with short read
lengths, whereas DEXSeq and rMATS show smaller areas
across all values of depth and read length.
We also considered an unbalanced configuration
where one replicate had 120 M reads and the other two
replicates had 10 M reads. In this hybrid configuration,
SUPPA2 recovered a high number of events and a high
number of true positives for SE events. On the other
hand, for A5/A3 events we observed a slight drop in
accuracy (Additional file 2: Table S3), probably due to a
high proportion of short variable regions in the alterna-
tive sites events (79 events (25%) of the A5/A3 events
involved a region of under 9 nt), which may be more
problematic for correct transcript quantification than
using direct mapping to splice junctions. Importantly,
although MAJIQ showed a high detection rate and
accuracy in the unbalanced configuration, it had to be
run with specialized parameters (“Methods”), whereas
SUPPA2 was run in the same way for all cases. Addition-
ally, SUPPA2 also showed high correlation values between
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the predicted and simulated ΔPSI values (Additional file 2:
Table S3), and similar to those obtained with rMATS and
MAJIQ. In light of these results, we can conclude that
SUPPA2 performs comparably to other methods under a
wide spectrum of sequencing conditions and, in particular,
it outperforms other methods at low sequencing depth
and short read length.
SUPPA2 provides accurate splicing change quantification
compared with experimental results
To further evaluate the accuracy of SUPPA2 in recovering
ΔPSI values we used 83 events that had been validated
experimentally by RT-PCR upon TRA2A and TRA2B
knockdown compared to control cells (Additional file 2:
Table S4; “Methods”) [17]. For each method, we compared
the ΔPSI estimated from RNA-seq with the ΔPSI from RT-
PCR. SUPPA2 agreement to the RT-PCR ΔPSI values was
similar to rMATS and MAJIQ (Fig. 3a; Additional file 2:
Table S5). Using two other independent RT-PCR datasets
published previously [9], SUPPA2 also showed similar
accuracy compared to rMATS andMAJIQ (Additional file 1:
Figure S3a, b; Additional file 2: Tables S6–S9). Finally, using
44 RT-PCR negative cassette events that did not show any
significant change upon the double knockdown of TRA2A
and TRA2B, SUPPA2 had a lower false positive rate com-
pared to the other methods (Fig. 3b; Additional file 2:
Tables S10 and S11).
SUPPA2 identifies experimentally reproducible splicing
changes not detected by other methods
The results described above suggest a general agreement
between the different methods in the detection of
significant differentially spliced events. To assess this
question, we performed a direct comparison of the re-
sults obtained from the four methods, SUPPA2, rMATS,
MAJIQ, and DEXSeq, using the same RNA-seq data for
the knockdown of TRA2A and TRA2B compared with
controls [17]. Since exon-cassette (SE; 48.71%) and alter-
native splice site (A5/A3; 37.71%) events are the most
frequent events in humans compared to mutual exclu-
sion (6.22%) or intron-retention (7.36%), we decided to
match SE and A5/A3 events across all four methods.
We were able to identify 7116 SE events and 2924 A5/
A3 events unambiguously detected by all four methods,
Fig. 2 Accuracy analysis with simulated data. a Proportion of events measured by each method (y-axis) from the 277 positive simulated cassette
events at different sequencing depths (x-axis), from 120 million (120M) down to five million (5M) paired-end reads, using 100-nt paired-end reads.
b As in a but for different read lengths (x-axis) at fixed depth (25 M). c True positive (TP) rate (in terms of percentage) for each method (y-axis) at
different sequencing depths (x-axis) for 100-nt paired-end reads. TPs were calculated as the number of statistically significant events according to
each method: corrected p value < 0.05 for SUPPA2, rMATS, and DEXSeq; and posterior(|ΔPSI| > 0.1) > 0.95 for MAJIQ. d As in c but for different
read lengths (x-axis) at fixed depth (25 M)
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i.e., they were measured and tested for significance by all
methods (Additional file 1: Figure S4a; Additional file 2:
Table S12; “Methods”).
For the 7116 SE events, each method found between 133
and 274 events to be significant, with 370 events predicted
as significant by any one method, but only 22 events
predicted by all four methods (Additional file 1: Figure
S4a). Similarly, 352 A5/A3 events were predicted to be sig-
nificant by at least one method, and only two predicted by
all four methods (Additional file 1: Figure S4a). Events
detected by more methods tended to have higher ΔPSI
values (Additional file 1: Figure S4b) and covered a smaller
range of gene expression values (Additional file 1: Figure
S4c). Despite the low detection overlap, the significant
events predicted by each method independently showed
enrichment of TRA2B CLIP tags and of Tra2 binding
motifs (Additional file 2: Table S13; Additional file 3: Sup-
plementary methods); hence, each set independently had
the expected properties related to the knockdown experi-
ment. It is possible that each method describes a different
subset of changes and generally misses others. To seek fur-
ther support for this point, we selected for experimental
validation 15 SE events and seven A3 events that had CLIP
tags and Tra2 motifs nearby the regulated exon. The seven
A3 events and six of the 15 SE events were predicted only
by SUPPA2, whereas the remaining nine were not predicted
by any of the four methods, but were significant according
to SUPPA2 before multiple test correction (Additional file 2:
Table S14). From these 15 SE events, five only showed one
PCR band and could not be evaluated. However, for the
rest, seven changed significantly according to the RT-PCR
(two-tailed t-test p value < 0.05), with six of them changing
in the same direction predicted by SUPPA2. Overall, nine
events changed in the same direction as predicted (Fig. 3c;
Additional file 2: Table S14). In particular, we validated a
new event in EML4 (Fig. 3d), a gene involved in cancer
through a fusion with ALK that is not present in MDA-
MB-231 cells [18]. In addition, we could measure six of the
seven A3 events; all were measured to change in the same
direction as predicted by SUPPA2 and four were significant
(two-tailed t-test p value < 0.05; Additional file 2: Table
S14). This analysis shows the value of using a suite of
methods based on different algorithms, like SUPPA2, to
reveal novel experimentally reproducible events that are
missed by other methods.
SUPPA2 finds biologically relevant event clusters across
multiple conditions
SUPPA2 is also able to analyze multiple conditions by com-
puting the pairwise differential splicing between conditions,
a b
c d
298 bp
124 bp
Control Tra2 double 
knockdown 
Fig. 3 Experimental validation of differentially splicing predictions by SUPPA2. a Comparison of predicted and experimentally validated ΔPSI
values for 83 cassette events differentially spliced between the double knockdown of TRA2A and TRA2B and control in MDA-MB-231 cells. We
show the cumulative proportion of cases (y-axis) according to the absolute difference between the predicted and the experimental value (|ΔPSI −
RTPCR|), for the events detected by each method: SUPPA2 (66), rMATS (78), and MAJIQ (72). Additionally, we give for each method the Pearson
correlation R between predicted and experimental values. b False positive rate (FPR) calculated using 44 RT-PCR negative events. FPR was
calculated as the proportion of the detected events that was found as significant by each method: SUPPA2 (1/31), rMATS (2/35), MAJIQ (2/36),
DEXSeq(2/25). c Experimental validation by RT-PCR of a subset of novel events with TRA2B CLIP tags and Tra2 motifs. These events include cases
that were only predicted by SUPPA2 (CHRAC1, NDRG3, METTL10) and cases that were not predicted by any method but were significant
according to SUPPA2 before multiple test correction (ERLEC1, PYGL, DCAF10, HAUS8, EML4, UBA3) (Additional file 2: Table S14). RT-PCR validation
was performed in triplicate. Error bars indicate the standard error of the mean. Cases that change significantly (p < 0.05) according to a two-tailed
t-test comparing the three values of the knockdown versus control are indicated with an asterisk. d Experimental validation of a new skipping
event in EML4 upon knockdown of TRA2A and TRA2B (three biological replicates shown in each case)
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and can detect groups of events with similar splicing pat-
terns across conditions using density-based clustering
(“Methods”). To evaluate the ability of SUPPA2 to cluster
events, we analyzed a 4-day time-course of differentiation
of human induced pluripotent stem cells (iPSCs) into bipo-
lar neurons [19], which had not been analyzed yet for alter-
native splicing. SUPPA2 identified 2780 regulated cassette
events (p value < 0.05), out of which 207 (8.4%) were micro-
exons (length < 28 nt), which represent an enrichment
(Fisher’s exact test p value < 2.2e-16, odds ratio = 3.94)
compared to a set of 20,452 non-regulated cassette events
(p value > 0.1), with the majority of these microexons (69%)
significantly more included in differentiated cells (ΔPSI > 0
and p value < 0.05 between the first and fourth day).
We evaluated the performance of the two density-based
cluster methods implemented in SUPPA2, DBSCAN [20],
and OPTICS [21], using different input parameters. In
spite of OPTICS requiring more computing time than
DBSCAN (43 vs 5 s), it produced slightly better clustering
results (Additional file 1: Figure S5a–d; Additional file 2:
Table S15). For a maximum reachability distance of 0.11,
i.e., maximum distance of an event to a cluster to be
considered part of the cluster, we obtained three well-
differentiated clusters (silhouette score = 0.572; Fig. 4a–c;
Additional file 2: Table S16). Cluster 0 increased inclusion
at late steps of differentiation and showed an enrichment
in microexons (32 out of 115 events) with respect to
unclustered regulated cassette events (Fisher’s exact test p
value = 0.0148, odds ratio = 5.3521). In contrast, clusters 1
and 2 decreased inclusion with differentiation, and con-
tained two (out of 20 events) and no microexons, respect-
ively. These results are in agreement with the previously
observed enrichment of microexon inclusion in differenti-
ated neurons [22, 23].
To further validate the findings with SUPPA2, we per-
formed a motif enrichment analysis in regulated events
compared to non-regulated events. Notably, compared
to the non-regulated events, the 2780 regulated cassette
events showed enrichment in binding motifs for the
RNA binding protein (RBP) SFPQ (z-score > 4), which
has been described before as a necessary factor for neur-
onal development [24]. Additionally, the differentially
spliced events in clusters were enriched in, among
others, CELF, RBFOX, ESRP, MBNL, and SRRM4 motifs
a b c 
Day Day Day 
e f d 
Fig. 4 Prediction and clustering of differentially spliced events across bipolar neuron differentiation. Density-based clustering performed on the
2780 regulated cassette events that change splicing significantly in at least one comparison between adjacent steps across four differentiation
stages (days after differentiation 0, 1, 3, 4). a–c The average PSI (y-axis) per stage (x-axis) of the events in the three clusters obtained. Microexons
(< 28 nt) are plotted in blue over the rest of the events in orange. d–f Motif enrichment associated with each of the three clusters in a–c in the
regions upstream (200 nt), exonic, and downstream (200 nt). Only enriched motifs associated with splicing factors that are differentially expressed
are shown in each comparison between differentiation stages (days after differentiation 0, 1, 3, 4). In red we indicate the splicing factors that are
upregulated and in blue those that are downregulated at each stage. The color intensity indicates the z-score of the motif enrichment. Motifs are
shown in each cluster and region where they are found enriched
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(Fig. 4d–f ), in concordance with the described role of
CELF, RBFOX, and SRRM4 genes in neuronal differenti-
ation [23, 25–27]. Consistent with these findings,
SRRM4 and members of the CELF and RBFOX families
showed upregulation at the initial steps of iPSC differen-
tiation into neurons (Additional file 1: Figure S5;
Additional file 2: Table S17). On the other hand, CELF5
and ESRP1 were downregulated during differentiation.
The MBNL3 gene showed initial upregulation at stage 1,
followed by downregulation at later stages (Additional file 1:
Figure S5; Additional file 2: Table S17). Notably, we found
that only the cluster enriched in microexon splicing inclu-
sion showed an enrichment of SRRM4 motifs upstream of
the regulated exons, in agreement with the previous de-
scription of SRRM4 binding upstream of microexons to
regulate their inclusion during neuronal differentiation [26],
and further supports the specificity of SRRM4 to regulate
microexons. Our results also suggest possible novel regula-
tors of neuronal differentiation, such as the MBNL proteins
in the regulation of events increasing exon inclusion and
ESRP in events that decrease exon inclusion (Fig. 4d–f).
We also used SUPPA2 to analyze differential splicing
across five stages of erythroblast differentiation [28]. In
this case we considered all event types for clustering.
For the optimal value of maximum reachability distance
(S = 0.1), we obtained two homogeneous and well-
differentiated clusters (silhouette score = 0.91), one for
events with low PSI that increased at the last differenti-
ation stage with 149 events, and a second cluster with
86 events that showed the opposite behavior (Add-
itional file 1: Figure S6). In agreement with previous re-
sults [29], we observed an enrichment of intron
retention events in the cluster of events that increased
inclusion at the late differentiation stage, as compared
with the other cluster, which does not include any
retained intron (Fisher’s exact test p value = 0.04958).
We conclude that SUPPA2 provides a powerful ap-
proach to analyze splicing across multiple conditions,
validated not only by intrinsic measures of clustering
consistency, but also by recovering known biological re-
sults and new features.
Discussion
Our extensive evaluations here indicate that SUPPA2
provides a broadly applicable solution to current chal-
lenges in the analysis of differential splicing from RNA
sequencing data across multiple conditions, and has
features that will make it attractive to many potential
users. SUPPA2 is faster than other methods and main-
tains a high accuracy, especially at low sequencing depth
and for short read length. Despite using less reads or
shorter reads, SUPPA2 could detect the majority of the
simulated events and maintained a high proportion of
true positives and low proportion of false positives.
SUPPA2 thus offers an unprecedented opportunity to
study splicing in projects with limited budgets, or to re-
use for splicing studies available sequencing datasets
with lower depth than usually required by other
methods. Additionally, the low computing and storage
requirements of SUPPA2 makes it possible to perform
fast differential splicing processing and clustering ana-
lysis on a laptop. Thus, coupled with fast methods for
transcript quantification [30–32], SUPPA2 facilitates the
study of alternative splicing across multiple conditions
without the need for large computational resources. The
simplicity and modular architecture of SUPPA2 also
makes it a very convenient tool in multiple contexts, as
PSI values from other methods and for other event
types, like complex events, or data types, like transcripts,
can be used in SUPPA2 for differential splicing analysis
or for clustering across conditions.
According to our simulated benchmarking analysis, as
well as others published before, it may seem that bio-
informatics methods used to analyze RNA-seq data tend
to coincide on a large number of events. However, using
real experimental data we actually observed low agree-
ment in targets between methods. These discrepancies
in target selection can be explained by various factors,
including the different ways in which a splicing change
is represented by each method (e.g., an event, an exon,
or a graph), how changes in splicing patterns are tested
by each method, and how biological and experimental
variability affects these tests. Intriguingly, the results
from each method do make sense biologically, in that
differentially spliced events were enriched in motifs and
mapped protein–RNA interaction sites related to the
depleted splicing factor. This makes it unlikely that any
one method provides a clear advantage in terms of the
results, and instead suggests that at least two or three
methods should be used to identify all the possible
significant splicing variants between different conditions.
In particular, we chose for comparison three other
methods with very different representations of the spli-
cing and statistical approach. The results we obtained
recommend use of two or more such tools to compre-
hensively monitor splicing complexity by picking out dif-
ferent sets of events that would not otherwise be
discovered, rather than identifying largely overlapping
groups of events. Supporting this point we could validate
experimentally events not predicted by any other
methods but predicted by SUPPA2. We further observed
that although most methods had the power to identify
small significant ΔPSI values, different methods tended
to agree on events with large splicing changes. Import-
antly, a fraction of these significant events with small
ΔPSI are indistinguishable from the variability observed
between replicates and hence are not likely to be bio-
logically relevant. SUPPA2 also performs a statistical test
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that can separate significant splicing changes from the
biological variability, providing thus an advantage to
identify biologically relevant changes across a wide range
of expression values. By exploiting the biological vari-
ability, without having to go back to the read data,
SUPPA2 provides a fast and accurate way to detect dif-
ferential splicing without the need for arbitrary global
ΔPSI thresholds.
Although SUPPA2 relies on genome annotation to de-
fine events, poorly annotated genomes can be improved
and extended before analysis by SUPPA2. In fact, recent
analyses have shown that improved annotations lead to
significantly better PSI estimates from RNA-seq when
benchmarked to high-resolution RT-PCR measurements
[33–35]. Current technological trends predict an in-
crease in the number of efforts to improve the transcrip-
tome annotation in multiple species and conditions [36].
In this direction, SUPPA2 could play a key role for the
systematic and rapid genome-wide analysis of splicing
following annotation and sample updates.
Conclusions
The speed, modularity, and accuracy of SUPPA2 enable
cost-effective use of RNA sequencing for the robust and
streamlined analysis of differential splicing across multiple
biological conditions.
Methods
Differential splicing
SUPPA2 uses transcript quantification to compute inclu-
sion values (PSI) of alternative splicing events across
multiple samples. Given the calculated PSI values per
sample, SUPPA2 considers two distributions: one for the
ΔPSI values between biological replicates and one for
the ΔPSI values between conditions. For the first distri-
bution, for each event SUPPA2 calculates the ΔPSI value
between each pair of biological replicates together with
the average abundance of the transcripts describing the
event across the same replicates:
Erep ¼ 1j Rc j
X
r∈Rc
log10
X
a
TPMa;r
 !
where r = 1,..,|Rc| runs over the replicates in each condi-
tion c = 1,2, and a indicates the two or more transcripts
describing the event, and TPMa,r indicates the abun-
dance of transcript a in replicate r in transcripts per mil-
lion (TPM) units. For the distribution between
conditions, the ΔPSI values are calculated as the differ-
ence of the means in the two conditions, together with
the average abundance of transcripts describing the
event across both conditions for each event:
Econd ¼ 12
X
c¼1;2
1
j Rc j
X
r∈Rc
log10
X
a
TPMa;r;c
 !
where TPMa,r,c indicates the abundance of transcript a
in replicate r in condition c in TPM units. Given the
observed ΔPSI and Econd values for an event between
conditions, its significance is calculated from the com-
parison with the ΔPSI distribution between replicates for
events with Erep values in the neighborhood of the ob-
served Econd. This neighborhood is defined by first
selecting the closest value E*rep from all points i from the
between-replicate distribution:
Erep ¼ mini Ei;rep−Econd
  
using binary search and selecting a fixed number of
events (1000 by default) around the E*rep value in the
interval or ordered values. The selected events define an
empirical cumulative density function (ECDF) over
|ΔPSI| from which a p value is calculated:
p ¼ 1−ECDF jΔPSIjð Þð Þ=2
Here we implicitly assume that the background distri-
bution is symmetric. SUPPA2 includes an option to cor-
rect for multiple testing using the Benjamini-Hochberg
method across all events from the same gene, as they
cannot be considered to be entirely independent of each
other, for which the false discovery rate (FDR) cut-off
can be given as input.
Clustering
SUPPA2 currently implements two density-based clus-
tering methods: DBSCAN [20] and OPTICS [21].
Density-based clustering has the advantage that one
does not need to specify the expected number of clus-
ters, and the choice between the two methods depends
mainly on the computational resources and the amount
of data. Both methods use the vectors of mean PSI
values per event and require as input the minimum
number of events in a cluster (N), which could be inter-
preted as the minimum expected size of the regulatory
modules. OPTICS also requires the maximum reachabil-
ity distance (S), which represents the maximum distance
in PSI space of an event to a cluster. On the other hand,
DBSCAN requires as input the maximum distance to
consider two events as cluster partners (D), which OP-
TICS calculates through an optimization procedure
allowing any value below S. DBSCAN allows simple and
fast data partitioning but has the drawback of being sen-
sitive to the input parameters. On the other hand, OP-
TICS, which can be seen as a generalization of
DBSCAN, explores the possible maximum values for D
beyond which clustering quality drops. OPTICS can thus
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potentially produce better clustering results since it is
not limited to a fixed radius of clustering, but it is penal-
ized by a greater computational cost. Clustering is per-
formed only with events that change significantly in at
least one pair of adjacent conditions. Three different dis-
tance metrics can be currently used: Euclidean, Manhat-
tan, and Cosine. Cluster qualities are reported using the
silhouette score [37], which indicates how well the
events are assigned to clusters, and the root mean
square standard deviation (RMSSTD), which measures
the homogeneity of each cluster. Additionally, the num-
ber and percentage of events in clusters are also re-
ported. Motif enrichment analysis was performed as
before [38] using MOSEA, available at https://github.-
com/comprna/MOSEA. Further details on the motif en-
richment and analysis of differential expression are
provided in Additional file 3: Supplementary material.
Simulated datasets
For the simulation we used the quantification of RefSeq
transcripts for the three control samples from [17]
(GSE59335) with Salmon [31] as theoretical abundances,
and considered genes with only two isoforms containing
a skipping exon (SE) or alternative splice site (A5/A3)
event and only one associated event. For the benchmark-
ing analysis, we selected a set of positive and a set of
negative events for each event type with the same num-
ber of randomly chosen events, 277 for SE events and
318 for A5/A3 events. For the positive set we simulated
differential splicing by exchanging the theoretical abun-
dance of their associated transcript values. We selected
to be positive events only those having an absolute dif-
ference of relative abundance greater than 0.2, so that
the simulated change was sufficiently large:
j TPM1−TPM2 j
TPM1 þ TPM2 > 0:2
where TPM1 and TPM2 are the abundances for the two
transcripts in the gene, given in TPM units. For the
negative set, we took an equal number of events without
exchanging their TPM values. These negative events had
a gene expression distribution and a distribution of tran-
script relative abundance similar to the positive events,
and an expected variability between conditions similar to
the variability between biological replicates. We used
RSEM [39] to simulate sequencing reads for the two con-
ditions, three replicates each, at various depths (120, 60,
25, 10 and 5 M 100-nt paired-end reads per sample) and
at various read lengths (100, 75, 50, and 25 nt, at a depth
of 25 M paired-end reads) (Additional file 2: Tables S1–
S3). Further details of the simulations are given in the
Additional file 3:Supplementary material. Datasets and
commands to reproduce these simulations are available at
https://github.com/comprna/SUPPA_supplementary_data.
Experimental datasets
We analyzed RNA-seq data for the double knockdown of
TRA2A and TRA2B in MDA-MB-231 cells and controls
with three replicates per condition [17] (GSE59335). For
benchmarking, we used 83 RT-PCR validated events for
comparison (Additional file 2: Tables S4 and S5) and 44
RT-PCR negative events (Additional file 2: Tables S12 and
S13). We also analyzed data from cerebellum and liver
mouse tissues covering eight different time points from two
full circadian cycles [40] (GSE54651) and performed a com-
parison with 50 events validated by RT-PCR [9] comparing
samples CT28, CT40, and CT52 in cerebellum with the
same circadian time points in liver (Additional file 2: Tables
S8 and S9). We also analyzed RNA-seq data for stimulated
and unstimulated Jurkat T cells and compared them with
RT-PCR validated events (no tested replicates) [9, 41]
(SRP059357; Additional file 2: Tables S10 and S11). From
these 54 RT-PCR validated events, we only used the 30
events that had experimental value |ΔPSI| > 0.05. For the
study of multiple conditions, we used RNA-seq samples
from a 4-day time-course for the differentiation of human
iPSCs into bipolar neurons [19] (GSE60548). Original data
were for days 0, 1, 3, and 4 after initiation of differentiation.
Additionally, we analyzed RNA-seq from five steps of
differentiating human erythroblasts [29] (GSE53635), with
three replicates per condition. RNA-seq reads from all
experiments were used to quantify human and mouse tran-
scripts from Ensembl (version 75, without pseudogenes)
with Salmon [31]. Reads were mapped to the human
(hg19) or mouse (mm10) genomes using TopHat [42]. All
methods other than SUPPA2 were used with these map-
pings. Cassette events from SUPPA2 and rMATS were
matched to the RT-PCR validated events in each dataset,
considering only those cases where the middle exon
matched exactly the validated exons and confirming the
flanking exons with the RT-PCR primers when available.
Ambiguous matches were discarded from the comparison.
For MAJIQ we selected the inclusion junction compatible
with the validated event that had the largest posterior prob-
ability for |ΔPSI| > 0.1. For DEXSeq we considered only
exonic regions that matched exactly with the regulated
exon of the experimentally validated cassette event. To se-
lect a set of cassette events common to all four methods,
we selected the events measured by both SUPPA2 and
rMATS such that the middle exon matched exactly a DEX-
Seq exonic region and did not appear in more than one
event from SUPPA2 or rMATS. From this set, we selected
those for which any of the two inclusion junctions was
present in MAJIQ, and selected the junction with the lar-
gest posterior probability for |ΔPSI| > 0.1. Further details
are provided in Additional file 3: Supplementary material.
Trincado et al. Genome Biology  (2018) 19:40 Page 9 of 11
Time performance
Running time was measured using the Unix time com-
mand time. For SUPPA2 running time was measured
independently of the transcript quantification step. Simi-
larly, for all other methods the running time did not in-
clude the read-mapping step. Time was measured
independently for PSI calculation and for differential
splicing analysis. All methods were run on a Unix machine
with 12 Gb of RAM and eight Intel Xeon 2-GHz
CPU cores.
Experimental validation
Details on the experimental validation are given in
Additional file 3: Supplementary material.
Software and datasets
SUPPA2 is available at https://github.com/comprna/SUPPA.
Commands and datasets used in this work are available at
https://github.com/comprna/SUPPA_supplementary_data.
Software for the motif enrichment analysis is available
at https://github.com/comprna/MOSEA.
Additional files
Additional file 1: Figures S1–S6. (PDF 3939 kb)
Additional file 2: Tables S1–S17. (XLSX 3050 kb)
Additional file 3: Supplementary methods. (PDF 315 kb)
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